Total Payments
$1,882
2024 Payments
$237.22
Companies
30
Transactions
108
Medicare Patients
6,717
Medicare Billing
$266,571
Payment Breakdown by Category
Food & Beverage$1,882 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,882 | 108 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $299.82 | 16 | $0 (2024) |
| Amgen Inc. | $255.23 | 10 | $0 (2023) |
| Novo Nordisk Inc | $221.17 | 14 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $156.88 | 6 | $0 (2024) |
| PFIZER INC. | $132.33 | 9 | $0 (2024) |
| Lilly USA, LLC | $111.05 | 6 | $0 (2024) |
| Astellas Pharma US Inc | $74.89 | 6 | $0 (2021) |
| Dexcom, Inc. | $60.68 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $57.11 | 4 | $0 (2023) |
| Merck Sharp & Dohme LLC | $54.29 | 4 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $237.22 | 13 | Novo Nordisk Inc ($66.59) |
| 2023 | $583.29 | 32 | AbbVie Inc. ($163.26) |
| 2022 | $525.59 | 23 | Amgen Inc. ($205.58) |
| 2021 | $191.72 | 13 | Janssen Pharmaceuticals, Inc ($26.70) |
| 2020 | $69.51 | 5 | PFIZER INC. ($41.39) |
| 2019 | $37.07 | 3 | Astellas Pharma US Inc ($13.94) |
| 2018 | $40.58 | 3 | Genentech USA, Inc. ($16.84) |
| 2017 | $197.05 | 16 | Astellas Pharma US Inc ($35.39) |
All Payment Transactions
108 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/29/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.23 | General |
| Category: NEUROSCIENCE | ||||||
| 09/24/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $13.81 | General |
| Category: Oncology | ||||||
| 09/11/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $17.03 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | PFIZER INC. | COMIRNATY (Biological), ABRYSVO | Food and Beverage | In-kind items and services | $15.51 | General |
| Category: VACCINES | ||||||
| 08/20/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $22.11 | General |
| Category: Diabetes | ||||||
| 07/17/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $21.36 | General |
| Category: Diabetes Care | ||||||
| 06/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $14.06 | General |
| Category: VACCINES | ||||||
| 05/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.64 | General |
| Category: Obesity | ||||||
| 04/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: Diabetes | ||||||
| 03/27/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.16 | General |
| Category: Diabetes | ||||||
| 03/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.80 | General |
| Category: Respiratory | ||||||
| 03/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $15.50 | General |
| Category: Diabetes | ||||||
| 01/11/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $25.59 | General |
| Category: NEUROSCIENCE | ||||||
| 12/13/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.83 | General |
| Category: Diabetes | ||||||
| 12/07/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | SYNJARDY (Drug) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: DIABETES | ||||||
| 12/01/2023 | AbbVie Inc. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $10.31 | General |
| Category: NEUROSCIENCE | ||||||
| 11/29/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.22 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.34 | General |
| Category: Gastroenterology | ||||||
| 11/06/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $14.55 | General |
| Category: Obesity | ||||||
| 10/26/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.62 | General |
| Category: NEUROSCIENCE | ||||||
| 10/05/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | TRADJENTA (Drug) | Food and Beverage | In-kind items and services | $13.45 | General |
| Category: DIABETES | ||||||
| 09/28/2023 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Respiratory | ||||||
| 09/21/2023 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: Inflammation | ||||||
| 09/05/2023 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $16.83 | General |
| Category: Diabetes | ||||||
| 08/31/2023 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $19.68 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 1,810 | 2,375 | $211,358 | $78,812 |
| 2022 | 27 | 1,640 | 2,198 | $167,207 | $63,064 |
| 2021 | 29 | 1,712 | 2,348 | $166,821 | $66,895 |
| 2020 | 25 | 1,555 | 2,104 | $156,786 | $57,801 |
Total Patients
6,717
Total Services
9,025
Medicare Billing
$266,571
Procedure Codes
114
All Medicare Procedures & Services
114 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 197 | 355 | $72,420 | $27,271 | 37.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 85 | 153 | $20,196 | $8,789 | 43.5% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 63 | 63 | $4,599 | $4,501 | 97.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 22 | 30 | $8,910 | $4,272 | 47.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 32 | $8,096 | $3,605 | 44.5% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 25 | 25 | $3,750 | $3,575 | 95.3% |
| 82306 | Vitamin d-3 level | Office | 2023 | 103 | 109 | $10,791 | $3,138 | 29.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 176 | 221 | $9,724 | $2,287 | 23.5% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 19 | 35 | $6,755 | $2,271 | 33.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 168 | 171 | $7,524 | $2,232 | 29.7% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 99 | 131 | $8,122 | $2,156 | 26.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 17 | 17 | $2,805 | $2,039 | 72.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 64 | 64 | $2,688 | $1,830 | 68.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 131 | 213 | $2,982 | $1,782 | 59.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 174 | 214 | $8,346 | $1,629 | 19.5% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 40 | 40 | $11,000 | $1,387 | 12.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 93 | 143 | $6,292 | $1,344 | 21.4% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 25 | 25 | $1,000 | $953.00 | 95.3% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 47 | 48 | $3,168 | $709.44 | 22.4% |
| 0134A | Adm sarscv2 bvl 50mcg/.5ml a | Office | 2023 | 18 | 18 | $792.00 | $686.16 | 86.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 24 | 26 | $2,574 | $552.53 | 21.5% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 27 | 44 | $1,584 | $357.69 | 22.6% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 15 | 19 | $1,311 | $342.38 | 26.1% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 13 | 13 | $429.00 | $220.74 | 51.5% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 33 | 33 | $1,452 | $186.78 | 12.9% |
About Dr. Melissa Rosso, MD
Dr. Melissa Rosso, MD is a Family Medicine healthcare provider based in Manhattan, Kansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/29/2009. The National Provider Identifier (NPI) number assigned to this provider is 1720216708.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Melissa Rosso, MD has received a total of $1,882 in payments from pharmaceutical and medical device companies, with $237.22 received in 2024. These payments were reported across 108 transactions from 30 companies. The most common payment nature is "Food and Beverage" ($1,882).
As a Medicare-enrolled provider, Rosso has provided services to 6,717 Medicare beneficiaries, totaling 9,025 services with total Medicare billing of $266,571. Data is available for 4 years (2020–2023), covering 114 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Manhattan, KS
- Active Since 06/29/2009
- Last Updated 07/25/2013
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1720216708
Products in Payments
- TEZSPIRE (Biological) $265.73
- VRAYLAR (Drug) $155.39
- UBRELVY (Drug) $131.98
- MOUNJARO (Drug) $84.87
- Ozempic (Drug) $83.17
- Rybelsus (Drug) $81.94
- XARELTO (Drug) $54.18
- DEXCOM G7 GSS (161) (Medical Supply) $45.97
- QUVIVIQ (Drug) $42.96
- GARDASIL 9 (Biological) $39.03
- EVENITY (Biological) $36.07
- Myrbetriq (Drug) $35.39
- COMIRNATY (Biological) $34.55
- Wegovy (Drug) $33.19
- PREVNAR 13 (Biological) $32.93
- JARDIANCE (Drug) $31.39
- BREZTRI (Drug) $29.87
- XIFAXAN (Drug) $28.97
- PREVNAR 20 (Biological) $27.40
- MYRBETRIQ (Drug) $27.35
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Manhattan
Bradley Harrison, M.d, M.D
Family Medicine — Payments: $451,744
Family Medicine $451,744
Dr. Kent Kiracofe, M.d, M.D
Family Medicine — Payments: $186,788
Family Medicine $186,788
Dr. Kyle Platz, D.o, D.O
Family Medicine — Payments: $52,764
Family Medicine $52,764
Bethany Duff, Md, MD
Family Medicine — Payments: $8,727
Family Medicine $8,727
Dr. Cary Herl, Md, MD
Family Medicine — Payments: $8,424
Family Medicine $8,424
Dr. Jacqi Lambert, M.d, M.D
Family Medicine — Payments: $8,316
Family Medicine $8,316